Understanding mild cognitive impairment as a prodrome to Alzheimer’s disease
How new blood-based biomarkers support earlier, more accurate diagnosis
Practical use and patient selection for monoclonal antibody therapies
Identifying and managing modifiable risk factors in primary care
Using cognitive assessment tools and collateral history effectively

 

Host: Dr David Lim | Total Time: 44 mins

Facilitator: Dr Stephanie Daly, General Practitioner

Experts: Prof Michael Woodward AM, Geriatrician and Dr Chrys Pulle, Geriatrician

 

Register for our fortnightly FREE WEBCASTS
Every second Tuesday | 7:00pm-9:00pm AEDT

Click here to register for the next one

See omnystudio.com/listener for privacy information.

<ul>
<li>Understanding mild cognitive impairment as a prodrome to Alzheimer&rsquo;s disease</li>
<li>How new blood-based biomarkers support earlier, more accurate diagnosis</li>
<li>Practical use and patient selection for monoclonal antibody therapies</li>
<li>Identifying and managing modifiable risk factors in primary care</li>
<li>Using cognitive assessment tools and collateral history effectively</li>
</ul>
&nbsp;
Host: Dr David Lim | Total Time: 44 mins
Facilitator:&nbsp;Dr Stephanie Daly,&nbsp;General Practitioner
Experts:&nbsp;Prof Michael Woodward AM, Geriatrician and Dr Chrys Pulle,&nbsp;Geriatrician
&nbsp;
Register for our fortnightly FREE WEBCASTS Every second Tuesday | 7:00pm-9:00pm AEDT
<a href="https://www.healthed.com.au/webcast/">Click here to register for the next one</a>
See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

The Clinical Takeaway podcast for healthcare professionals features leading experts on important topics that can positively change the way you practice. Each episode is eligible for continued professional development (CPD).

Advertisement